STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMAX
  4. [Form 4] IMAX CORP Insider Trading Activity

IMAX Form 4: CLO Robert Lister option exercise and sale on Nov 7

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

IMAX Corp (IMAX): Form 4 insider activity. On 11/07/2025, Chief Legal Officer and Sr. EVP Robert D. Lister exercised stock options to acquire 50,143 common shares at $22.49 pursuant to a Rule 10b5-1 plan dated June 11, 2025, then sold 50,143 shares at $34.6652 the same day. After these transactions, he directly beneficially owned 161,421 common shares. The filing notes remaining restricted share units of 70,609. The options were issued in 2019 and set to expire on March 7, 2026, and the derivative balance following these transactions is listed as 0.

Positive

  • None.

Negative

  • None.

Insights

Planned option exercise and same‑day sale; neutral impact.

Robert D. Lister executed a pre‑planned transaction under a Rule 10b5‑1 plan, exercising options for 50,143 shares at $22.49 and selling the same number at $34.6652 on 11/07/2025. Such plans automate trades to reduce discretion.

Post‑trade direct beneficial ownership is 161,421 common shares, with 70,609 RSUs remaining. The derivative table shows 0 remaining for the exercised option grant, which was issued in 2019 with expiration on 03/07/2026.

Form 4 activity reflects personal portfolio movements and does not alter operating fundamentals. Actual market effect depends on overall trading volume and holder decisions.

Insider LISTER ROBERT D
Role Chief Legal Officer Sr Exec VP
Sold 50,143 shs ($1.74M)
Type Security Shares Price Value
Conversion stock options (to buy) 50,143 $22.49 $1.13M
Conversion common shares 50,143 $22.49 $1.13M
Sale common shares 50,143 $34.6652 $1.74M
holding common shares (opening balance) -- -- --
Holdings After Transaction: stock options (to buy) — 0 shares (Direct); common shares — 211,564 shares (Direct); common shares (opening balance) — 161,421 shares (Direct)
Footnotes (1)
  1. Represents the conversion upon exercise of stock options into common shares, pursuant to a 10b5-1 Plan dated June 11, 2025. These options were issued in 2019 and are set to expire on March 7, 2026. The stock options became exercisable in four installments: 12,535 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 12,538 on March 7, 2023. Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 161,421, respectively.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LISTER ROBERT D
(Last) (First) (Middle)
902 BROADWAY
20TH FLOOR
(Street)
NEW YORK NY 10010-6002
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer Sr Exec VP
3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common shares (opening balance) 161,421 D
common shares 11/07/2025 C 50,143(1) A $22.49 211,564 D
common shares 11/07/2025 S 50,143 D $34.6652 161,421 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
stock options (to buy)(2) $22.49 11/07/2025 C 50,143 (3) 03/07/2026 common shares 50,143 $22.49 0(4) D
Explanation of Responses:
1. Represents the conversion upon exercise of stock options into common shares, pursuant to a 10b5-1 Plan dated June 11, 2025.
2. These options were issued in 2019 and are set to expire on March 7, 2026.
3. The stock options became exercisable in four installments: 12,535 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 12,538 on March 7, 2023.
4. Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 161,421, respectively.
Remarks:
/s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister) 11/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did IMAX (IMAX) disclose in this Form 4?

An insider, Robert D. Lister, exercised options for 50,143 shares at $22.49 and sold 50,143 shares at $34.6652 on 11/07/2025 under a Rule 10b5-1 plan.

Was the IMAX insider trade under a Rule 10b5-1 plan?

Yes. The filing cites a Rule 10b5-1 plan dated June 11, 2025 governing the transactions.

What is Robert D. Lister’s ownership after the transactions?

He directly beneficially owned 161,421 common shares and had 70,609 restricted share units remaining.

What prices were reported for the IMAX insider’s transactions?

Option exercise price: $22.49 per share; sale price: $34.6652 per share.

What happened to the exercised IMAX stock options?

They were issued in 2019, set to expire on March 7, 2026, and the filing shows 0 remaining for that grant after exercise.

What is Robert D. Lister’s role at IMAX?

He is an officer: Chief Legal Officer and Senior Executive Vice President.